This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (39)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Bacterial Infections  • Neurology  • Meningitis  • Public Health, Other  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

The Evolving Epidemiology of the ET-5 Strain

Marion Diermayer, MD; Katrina Hedberg, MD, MPH; Frederick Hoesly, MD, MPH; Marc Fischer, MD; Bradley Perkins, MD; Michael Reeves, PhD; David Fleming, MD

JAMA. 1999;281:1493-1497.

Context  In 1993, Oregon's incidence of serogroup B meningococcal disease began to rise because of a highly clonal group of strains designated enzyme type 5 (ET-5), the first such increase observed in the United States.

Objective  To evaluate the impact that the ET-5 strain has had on the epidemiology of meningococcal disease in Oregon.

Design and Setting  Epidemiologic analysis of surveillance data on Oregon meningococcal disease cases from 1987 through 1996 and multilocus enzyme electrophoresis typing of serogroup B isolates from June 1993 through April 1995 and from April through June 1996.

Patients  A total of 836 persons with invasive meningococcal disease.

Main Outcome Measures  Disease frequency and clonality of strains.

Results  Serogroup B disease incidence rates more than doubled from the preepidemic period in 1987-1992 (1.0 case per 100,000 population) to the recent epidemic period in 1995-1996 (2.2 cases per 100,000). The age-specific incidence rate of serogroup B disease among those 15 through 19 years old increased 13-fold between the preepidemic period (0.5 case per 100,000) and 1995-1996 (6.4 cases per 100,000). However, the proportion of cases with meningococcemia and the case-fatality rate did not change. Of 99 Neisseria meningitidis isolates obtained from 1993-1995, 88 (89%) belonged to the ET-5 complex. Of these, 69 (78%) were a single clone, designated 301. Of 20 serogroup B isolates from 1996, 18 (90%) belonged to the ET-5 complex; 17 (94%) were the 301 clone.

Conclusion  Serogroup B meningococcal disease incidence continues at high levels in Oregon with increasing predominance of the ET-5 clonal strains.

Author Affiliations: Oregon Health Division, Portland (Drs Diermayer, Hedberg, Hoesly, and Fleming); the Division of Field Epidemiology, Epidemiology Program Office (Dr Diermayer), and the Meningitis and Special Pathogens Branch, Division of Bacterial and Mycotic Diseases (Drs Fischer, Perkins, and Reeves), Centers for Disease Control and Prevention, Atlanta, Ga.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED ARTICLES

Immunogenicity of 2 Serogroup B Outer-Membrane Protein Meningococcal Vaccines: A Randomized Controlled Trial in Chile
Jordan W. Tappero, Rosanna Lagos, Aurora Maldonado Ballesteros, Brian Plikaytis, Derrick Williams, Janet Dykes, Linda L. Gheesling, George M. Carlone, E. Arne Høiby, Johan Holst, Hanne Nøkleby, Einar Rosenqvist, Gustavo Sierra, Concepción Campa, Franklin Sotolongo, Jeanette Vega, Julio Garcia, Patricio Herrera, Jan T. Poolman, and Bradley A. Perkins
JAMA. 1999;281(16):1520-1527.
ABSTRACT | FULL TEXT  

Serogroup B Meningococcal Disease: New Outbreaks, New Strategies
Jay D. Wenger
JAMA. 1999;281(16):1541-1543.
EXTRACT | FULL TEXT  

April 28, 1999
JAMA. 1999;281(16):1557-1558.
EXTRACT | FULL TEXT  

Meningitis in children
JAMA. 1999;281(16):1560.
PDF  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prospects for Vaccine Prevention of Meningococcal Infection
Harrison
Clin. Microbiol. Rev. 2006;19:142-164.
ABSTRACT | FULL TEXT  

Vaccine Potential of the Neisseria meningitidis 2086 Lipoprotein
Fletcher et al.
Infect. Immun. 2004;72:2088-2100.
ABSTRACT | FULL TEXT  

Sequence Diversity of Neisseria meningitidis 16S rRNA Genes and Use of 16S rRNA Gene Sequencing as a Molecular Subtyping Tool
Sacchi et al.
J. Clin. Microbiol. 2002;40:4520-4527.
ABSTRACT | FULL TEXT  

The meningococcus tamed?
Pollard and Moxon
Arch. Dis. Child. 2002;87:13-17.
ABSTRACT | FULL TEXT  

Invasive Meningococcal Disease in Scotland, 1994 to 1999, with Emphasis on Group B Meningococcal Disease
Kyaw et al.
J. Clin. Microbiol. 2002;40:1834-1837.
ABSTRACT | FULL TEXT  

Invasive Meningococcal Disease in Adolescents and Young Adults
Harrison et al.
JAMA 2001;286:694-699.
ABSTRACT | FULL TEXT  

Meningococcal Disease
Rosenstein et al.
NEJM 2001;344:1378-1388.
FULL TEXT  

Distribution of Neisseria meningitidis Serogroup B Serosubtypes and Serotypes Circulating in the United States
Tondella et al.
J. Clin. Microbiol. 2000;38:3323-3328.
ABSTRACT | FULL TEXT  

There's Something About Serogroup B Meningococci
JWatch Infect. Diseases 1999;1999:19-19.
FULL TEXT  

Serogroup B Meningococcal Disease: New Outbreaks, New Strategies
Wenger
JAMA 1999;281:1541-1543.
FULL TEXT